Warttig S, Alderson P, Campbell G, Smith AF. Interventions for treating inadvertent postoperative hypothermia. Cochrane Database Syst Rev. 2014 Nov 20;11:CD009892. doi: 10.1002/14651858.CD009892.pub2
Mahida S, Algarni M, Rittenhouse B. Effect of excluding non-patient benefits as an element on Acmg newborn screening (Nbs) recommendations. Poster presented at the 2014 ISPOR 17th Annual European Congress; November 11, 2014. Amsterdam, Netherlands. [abstract] Value Health. 2014 Nov 1; 17(7):PA541. doi: 10.1016/j.jval.2014.08.1739
Ling CS, Heyes AE. Pricing and reimbursement environment for a biologic obtaining a licence in a second indication in key European countries. Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam, The Netherlands.
Warttig S, Ward S, Rogers G, Guideline Development Group. Diagnosis and management of gallstone disease: summary of NICE guidance. BMJ. 2014 Oct 30;349:g6241. doi: 10.1136/bmj.g6241
Mordin M, Masaquel C, Abbott C, Copley-Merriman C. Factors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a randomised, double-blind, placebo-controlled study. BMJ Open. 2014 Oct 16;4(10):e005150. doi: 10.1136/bmjopen-2014-005150
Lebwohl M, Mordin MM, Mallya UG, Gnanasakthy A, Fox T. Secukinumab treatment provides fast relief from patient-reported psoriasis burden. Poster presented at the 23rd European Academy of Dermatology and Venereology Congress; October 2, 2014. Amsterdam, The Netherlands.
Colosia A, Njue A, Trask PC, Olivares R, Khan S, Abbe A, Police R, Wang J, Ruiz-Soto R, Kaye JA, Awan F. Clinical efficacy and safety in relapsed/refractory diffuse large B-cell lymphoma: a systematic literature review. Clin Lymphoma Myeloma Leuk. 2014 Oct;14(5):343-55. doi: 10.1016/j.clml.2014.02.012
Alderson P, Campbell G, Smith AF, Warttig S, Nicholson A, Lewis SR. Thermal insulation for preventing inadvertent perioperative hypothermia. Cochrane Database Syst Rev. 2014 Jun 4;6:CD009908. doi: 10.1002/14651858.CD009908.pub2
Copley-Merriman C, Zelt S, Stone G, Barrows SM, Mordin MM, Hogue SL. Emerging-market payer needs: how should these countries be included in dermatology drug development plans? Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 4, 2014.
Lebwohl M, Karpov A, Zhao Y, Mordin MM, Elewski B. Secukinumab impact on patient-reported psoriasis symptoms: an analysis of the psoriasis symptom diary (ERASURE study). Poster presented at the Society of Dermatology Physicians Assistants Annual Summer Dermatology Conference; May 29, 2014. Indianapolis, IN.
D'Souza VK, Bartis D, Wang Q. HDAC inhibitors may regulate EMT in human alveolar epithelial cells. Poster presented at the 12th ERS Lung Science Conference; March 20, 2014. Estoril, Portugal.